Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Ark Therapeutics Group plc    AKT   GB0034251727

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Company
Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer.The company was founded by Peter Stephen Keen, John W. Martin, Seppo... 
Sector
Pharmaceuticals
Calendar
03/11Earnings Release
More about the company
Chart ARK THERAPEUTICS GROUP PLC
Duration : Period :
Ark Therapeutics Group plc Technical Analysis Chart | AKT | GB0034251727 | 4-Traders
Full-screen chart
Latest news on ARK THERAPEUTICS GROUP PLC
01/12 ALLERGY THERAPEUTICS : To Post 4% Rise In First-Half Revenue
2014 ARK THERAPEUTICS GROUP PLC : Reverse Split: 1 for 100
2014 ARK THERAPEUTICS : Posting of Circular
2014 ARK THERAPEUTICS : Says Proposed Reverse Takeover Plan Progressing Well
2014 ARK THERAPEUTICS : Half Yearly Report and Change of Registered Office
2014 ARK THERAPEUTICS : Results of AGM and Board Changes
2014 ARK THERAPEUTICS : Blocklisting Interim Review
2014 ARK THERAPEUTICS : Interim Management Statement
More news
Sector news Generic Pharmaceuticals
03:21a Shire shares jump as drug approval vindicates $5.2 billion NPS purchase
02:23a SHIRE : Comments on FDA Approval of NatparaÃ?®
02:16a SHIRE : Says Natpara Approval Further Vindication Of NPS Pharma Buy
Plus d'actualités du secteur Generic Pharmaceuticals


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF